A series of new Knoevenagel adducts, bearing two indolinone systems, has been synthe-sized and evaluated on 60 human cancer cell lines according to protocols available at the National Cancer Institute (Bethesda, MD, USA). Some derivatives proved to be potent antiproliferative agents, showing GI50 values in the submicromolar range. Compound 5b emerged as the most active and was further studied in Jurkat cells in order to determine the effects on cell-cycle phases and the kind of cell death induced. Finally, oxidative stress and DNA damage induced by compound 5b were also analyzed.
Morigi R., Catanzaro E., Locatelli A., Calcabrini C., Pellicioni V., Leoni A., et al. (2021). Synthesis and biological evaluation of new bis-indolinone derivatives endowed with cytotoxic activity. MOLECULES, 26(20), 1-15 [10.3390/molecules26206277].
Synthesis and biological evaluation of new bis-indolinone derivatives endowed with cytotoxic activity
Morigi R.;Catanzaro E.;Locatelli A.
;Calcabrini C.;Pellicioni V.;Leoni A.;Fimognari C.
2021
Abstract
A series of new Knoevenagel adducts, bearing two indolinone systems, has been synthe-sized and evaluated on 60 human cancer cell lines according to protocols available at the National Cancer Institute (Bethesda, MD, USA). Some derivatives proved to be potent antiproliferative agents, showing GI50 values in the submicromolar range. Compound 5b emerged as the most active and was further studied in Jurkat cells in order to determine the effects on cell-cycle phases and the kind of cell death induced. Finally, oxidative stress and DNA damage induced by compound 5b were also analyzed.File | Dimensione | Formato | |
---|---|---|---|
Synthesis and Biological Evaluation of New Bis-Indolinone Derivatives Endowed with Cytotoxic Activity.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
2.09 MB
Formato
Adobe PDF
|
2.09 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.